Inflammation induced by incomplete radiofrequency ablation accelerates tumor progression and hinders PD-1 immunotherapy
Radiofrequency ablation is used to treat metastatic colorectal cancer. In this study, the authors show that incomplete ablation of tumours results in metastases and show in mouse models that the chemokine CCL2 recruits myeloid cells to the partially ablated tumours, which can block T cell function.
Enregistré dans:
Auteurs principaux: | Liangrong Shi, Junjun Wang, Nianhua Ding, Yi Zhang, Yibei Zhu, Shunli Dong, Xiaohui Wang, Changli Peng, Chunhui Zhou, Ledu Zhou, Xiaodong Li, Hongbing Shi, Wei Wu, Xueyin Long, Changping Wu, Weihua Liao |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7ee06799e14541969149a6f48d4cd21b |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Transcatheter chemoembolization plus percutaneous radiofrequency ablation versus laparoscopic radiofrequency ablation: improved outcome for inoperable hepatocellular carcinoma
par: Bin Chai, et autres
Publié: (2021) -
Radiofrequency ablation of the lateral palatal space for snoring
par: B. Tucker Woodson, et autres
Publié: (2017) -
Optical signatures of radiofrequency ablation in biological tissues
par: Pranav Lanka, et autres
Publié: (2021) -
Combination therapy with low-frequency ultrasound irradiation and radiofrequency ablation as a synergistic treatment for pancreatic cancer
par: Huiyang Wang, et autres
Publié: (2021) -
Predictors of Recurrence of AF in Patients After Radiofrequency Ablation
par: Iskren Garvanski, et autres
Publié: (2019)